Free Trial
NASDAQ:CLBTW

Cellebrite DI (CLBTW) Stock Price, News & Analysis

$3.04
+0.18 (+6.29%)
(As of 04:15 PM ET)
Today's Range
$2.80
$3.04
50-Day Range
$1.79
$2.86
52-Week Range
$0.71
$3.04
Volume
10,734 shs
Average Volume
60,467 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

CLBTW Stock Price History

CLBTW Stock News Headlines

See More Headlines
Receive CLBTW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Software - Infrastructure
Sub-Industry
N/A
Current Symbol
NASDAQ:CLBTW
Fax
N/A
Employees
1,008
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$343.46 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Yossi Carmil (Age 56)
    Founder, CEO & Director
    Comp: $1.14M
  • Ms. Dana Gerner (Age 57)
    Chief Financial Officer
    Comp: $649k
  • Mr. Ronnen Armon (Age 61)
    Chief Products & Technologies Officer
    Comp: $516k
  • Mr. Leeor Ben-Peretz (Age 48)
    Chief Strategy Officer
    Comp: $470k
  • Mr. Thomas E. Hogan (Age 65)
    Executive Chairman
  • Andrew Kramer
    Vice President of Investor Relations
  • Ms. Ayala Berler Shapira (Age 53)
    General Counsel & Chief Compliance Officer
  • Mr. David Nicholas Gee (Age 57)
    Chief Marketing Officer
  • Ms. Zohar Tadmor-Eilat (Age 53)
    Chief People Officer
  • Mr. Marcus Jewell (Age 51)
    Global Chief Revenue Officer

CLBTW Stock Analysis - Frequently Asked Questions

How have CLBTW shares performed in 2024?

Cellebrite DI's stock was trading at $1.57 at the beginning of the year. Since then, CLBTW shares have increased by 85.4% and is now trading at $2.91.
View the best growth stocks for 2024 here
.

Are investors shorting Cellebrite DI?

Cellebrite DI saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 7,200 shares, an increase of 7.5% from the May 15th total of 6,700 shares. Based on an average trading volume of 56,500 shares, the days-to-cover ratio is presently 0.1 days.
View Cellebrite DI's Short Interest
.

Who are Cellebrite DI's major shareholders?

Cellebrite DI's stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Cellebrite DI?

Shares of CLBTW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLBTW) was last updated on 6/12/2024 by MarketBeat.com Staff

From Our Partners